Back to search

United Kingdom· GB-APID-8288311000001104

Pabrinex Intramuscular High Potency solution for injection 5ml and 2ml ampoules

A medicinal product, registered in United Kingdom by Kyowa Kirin International UK NewCo Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedPabrinex Intramuscular High Potency s…ATC—REGISTER NO.GB-APID-8288311000001…PACKS LISTED1CHECKEDOctober 2, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Manufacturer
Kyowa Kirin International UK NewCo Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
October 2, 2026

Packs & prices · 1

  • gtin
    5027229000036

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5a94d651-0dce-4520-aa2c-de721f0ef1b6
GET /v1/drugs/5a94d651-0dce-4520-aa2c-de721f0ef1b6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "8288311000001104",
  "desc": "Pabrinex Intramuscular High Potency solution for injection 5ml and 2ml ampoules (Kyowa Kirin International UK NewCo Ltd)",
  "form": "Not applicable",
  "vpid": "8307411000001101",
  "source": "dmd",
  "vtm_id": null,
  "strength": null,
  "substance": null,
  "ingredient": null,
  "supplier_code": "42062411000001105"
}

See everything about Pabrinex.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.